The pS2/TFF1 trefoil factor, from basic research to clinical applications

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1378, Issue 1, 1998, Pages

  Ribieras, Stéphane ^a   Tomasetto, Catherine ^a   Rio, Marie Christine ^a  

^a CNRS   (France)

Author keywords

Breast cancer; Gastrointestinal tract; ITF TFF3; Motogene; Mucosa ulceration; Mucus; Neuropeptide; pS2 TFF1; SP TFF2; Stomach ontogenesis; Trefoil factor; Tumor suppressor

Indexed keywords

TREFOIL PEPTIDE;

BREAST CANCER; BREAST CARCINOGENESIS; CELL DIFFERENTIATION; CELL MOTILITY; CELL PROLIFERATION; EMBRYO DEVELOPMENT; GENE CONTROL; GENE STRUCTURE; HUMAN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; STOMACH MUCOSA; STOMACH MUCUS; STOMACH ULCER;

ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL MOVEMENT; FEMALE; GASTROINTESTINAL DISEASES; GROWTH SUBSTANCES; HUMANS; MICE; MUCINS; MUSCLE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; NEUROPEPTIDES; PEPTIDES; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

LOTUS;

EID: 0032547383     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(98)00016-X     Document Type: Review

References (122)

1. Alison M.R., Chinery R., Poulsom R., Ashwood P., Longcroft J.M., Wright N.A. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J. Pathol. 175:1995;405-414.
2. Babyatsky M.W., de Beaumont M., Thim L., Podolsky D.K. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology. 110:1996;489-497.
3. Baker M.E. Oestrogen-induced pS2 protein is similar to pancreatic spasmolytic polypeptide and the kringle domain. Biochem. J. 253:1988;307-309.
4. Berry M., Nunez A.M., Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA. 86:1989;1218-1222.
5. Bonkhoff H., Stein U., Welter C., Remberger K. Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation. Hum. Pathol. 26:1995;824-828.
6. Burmeister M., Meyer G.E. The trefoil gene maps to mouse chromosome 17. Mamm. Genome. 8:1997;223-224.
7. Campbell-Thompson M.L. Estrogen receptor α and β expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats. Biochem. Biophys. Res. Commun. 240:1997;478-483.
8. Carr M. H NMR-based determination of the secondary structure of porcine pancreatic spasmolytic polypeptide: one of a new family of 'trefoil' motif containing cell growth factors. Biochemistry. 31:1992;1998-2004.
9. Chadwick M.P., May F.E., Westley B.R. Production and comparison of mature single-domain 'trefoil' peptides pNR-2/pS2 Cys58 and pNR-2/pS2 Ser58. Biochem. J. 308:1995;1001-1007.
10. Chadwick M.P., Westley B.R., May F.E. Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. Biochem. J. 327:1997;117-123.
11. P. Chambon, M.C. Rio, J.P. Bellocq, Peptides derived from the pS2 protein. European patent No. 0345315 (1993); USA patent No. 5,635,596 (1997); Japanese patent No. 2648952 (1997).
12. Chinery R., Poulsom R., Elia G., Hanby A.M., Wright N.A. Expression and purification of a trefoil peptide motif in a beta-galactosidase fusion protein and its use to search for trefoil-binding sites. Eur. J. Biochem. 212:1993;557-563.
13. Chinery R., Bates P.A., De A., Freemont P.S. Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Lett. 357:1995;50-54.
14. Chinery R., Cox H.M. Immunoprecipitation and characterization of a binding protein specific for the peptide, intestinal trefoil factor. Peptides. 16:1995;749-755.
15. Chinery R., Playford R.J. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin. Sci. 88:1995;401-403.
16. Chinery R., Williamson J., Poulsom R. The gene encoding human intestinal trefoil factor (TFF3) is located on chromosome 21q22.3 clustered with other members of the trefoil peptide family. Genomics. 32:1996;281-284.
17. Chinery R., Poulsom R., Cox H.M. The gene encoding mouse intestinal trefoil factor: structural organization, partial sequence analysis and mapping to murine chromosome 17q. Gene. 171:1996;249-253.
18. Cook G.A., Yeomans N.D., Giraud A.S. Temporal expression of trefoil peptides in the TGF-alpha knockout mouse after gastric ulceration. Am. J. Physiol.-Gastrointest. Liver Physiol. 33:1997;G1540-G1549.
19. De A., Brown D.G., Gorman M.A., Carr M., Sanderson M.R., Freemont P.S. Crystal structure of a disulfide-linked 'trefoil' motif found in a large family of putative growth factors. Proc. Natl. Acad. Sci. USA. 91:1994;1084-1088.
20. Dignass A., Lynch-Devaney K., Kindon H., Thim L., Podolski D.K. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J. Clin. Invest. 94:1994;376-383.
21. Duclos B., Rio M.C., Reimund J.M., Chamouard P., Derlon A., Baumann R., Chambon P., Weill J.P. Increased pS2 secretion in serum of Crohn's disease patients. Gastroenterology. 100:1991;A105.
22. Efstathiou J.A., Noda M., Rowan A., Dixon C., Chinery R., Jawhari A., Hattori T., Wright N.A., Bodmer W.F., Pignatelli M. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc. Natl. Acad. Sci. USA. 95:1998;3122-3127.
23. Foekens J.A., Rio M.C., Seguin P., van Putten W.L., Fauque J., Nap M., Klijn J.G., Chambon P. Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res. 50:1990;3832-3837.
24. Frandsen E.K. Receptor binding of pancreatic spasmolytic polypeptide in intestinal mucosal cells and membranes. Regul. Peptides. 20:1988;45-52.
25. Gajhede M., Petersen T.N., Henriksen A., Petersen J.F.W., Dauter Z., Wilson K.S., Thim L. Pancreatic spasmolytic polypeptide: first three dimensional structure of a member of the mammalian trefoil family of peptides. Structure. 1:1993;253-262.
26. Gillesby B.E., Stanostefano M., Porter W., Safe S., Wu Z.F., Zacharewski T.R. Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression. Biochemistry. 36:1997;6080-6089.
27. Gmachl M., Berger H., Thalhammer J., Kreil G. Dermal glands of Xenopus laevis contain a polypeptide with a highly repetitive amino acid sequence. FEBS Lett. 260:1990;145-148.
28. Gött P., Beck S., Machado J.C., Carneiro F., Schmitt H., Blin N. Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression. Eur. J. Hum. Genet. 4:1996;308-315.
29. Guerin M., Sheng Z.M., Andrieu N., Riou G. Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene. 5:1990;131-135.
30. Hähnel E., Joyce R., Sterrett G., Harvey J., Hähnel R. Detection of estradiol-induced messenger RNA (pS2) in uninvolved breast tissue from mastectomies for breast cancer. Breast Cancer Res. Treatm. 20:1991;167-176.
31. Hanby A.M., Poulsom R., Singh S., Elia G., Jeffery R.E., Wright N.A. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology. 105:1993;1110-1116.
32. Hauser F., Hoffmann W. xP1 and xP4. P-domain peptides expressed in Xenopus laevis stomach mucosa. J. Biol. Chem. 266:1991;21306-21309.
33. Hauser F., Roeben C., Hoffman W. xP2, a new member of the P-domain peptide family of potential growth factors, is synthesized in Xenopus laevis skin. J. Biol. Chem. 267:1992;14451-14455.
34. Hauser F., Poulsom R., Chinery R., Rogers L.A., Hanby A.M., Wright N.A., Hoffmann W. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc. Natl. Acad. Sci. USA. 90:1993;6961-6965.
35. Henry J.A., Bennett M.K., Piggott N.H., Levett D.L., May F., Westley B.R. Expression of the pNR2/pS2 protein in diverse human epithelial tumors. Br. J. Cancer. 64:1991;677-682.
36. Higashiyama M., Doi O., Kodama K., Yokouchi H., Inaji H., Nakamori S., Tateishi R. Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma. Eur. J. Cancer. 30A:1994;792-797.
37. Hirota M., Miyashita S., Hayashi H., Furukawa Y., Hayashi K. pS2 gene especially expressed in the late G1/S phase of mouse astrocytes. Neurosci. Lett. 171:1994;49-51.
38. Hirota M., Awatsuji H., Sugihara Y., Miyashita S., Furukawa Y., Hayashi K. Expression of pS2 gene in rat brain. Biochem. Mol. Biol. Int. 35:1995;1079-1084.
39. Hoffmann W., Hauser F. The P-domain or trefoil motif: a role in renewal and pathology of mucous epithelia? Trends Biochem. Sci. 18:1993;239-243.
40. Itoh H., Tomita M., Uchino H., Kobayashi T., Kataoka H., Sekiya R., Nawa Y. cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis. Biochem. J. 318:1996;939-944.
41. Jakowlev S., Breatnach R., Jeltsch J.M., Masiakowski P., Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF7. Nucleic Acids Res. 12:1984;2861-2878.
42. Jeffrey G.P., Oates P.S., Wang T.C., Babyatsky M.W., Brand S.J. Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells. Gastroenterology. 106:1994;336-345.
43. Jeltsch J.M., Roberts M., Schatz C., Garnier J.M., Brown A.M., Chambon P. Structure of the human oestrogen-responsive gene pS2. Nucleic Acids Res. 15:1987;1401-1414.
44. Jorgensen K.D., Diamant B., Jorgensen K.H., Thim L. Pancreatic spasmolytic polypeptide (PSP): pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul. Peptides. 3:1982;231-243.
45. Kida N., Yoshimura T., Mori K., Hayashi K. Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7). Cancer Res. 49:1989;3494-3498.
46. Kindon H., Pothoulakis C., Thim L., Lynch-Devaney K., Podolsky D.K. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology. 109:1995;516-523.
47. Klijn J.G., Berns P.M., Bontenbal M., Alexieva-Figush J., Foekens J.A. Clinical breast cancer, new developments in selection and endocrine treatment of patients. J. Steroid Biochem. Mol. Biol. 43:1992;211-221.
48. Konturek P.C., Brzozowski T., Konturek S.J., Elia G., Wright N.A., Sliwowski Z., Thim L., Hahn E.G. Role of spasmolytic polypeptide in healing of stress induced gastric lesions in rats. Regul. Peptides. 68:1997;71-79.
49. Koshiyama M., Yoshida M., Konishi M., Takemura M., Yura Y., Matsushita K., Hayashi M., Tauchi K. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status. Int. J. Cancer. 74:1997;237-244.
50. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Hâggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β Endocrinology. 138:1997;863-870.
51. Lefebvre O., Wolf C., Kédinger M., Chenard M.P., Tomasetto C., Chambon P., Rio M.C. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J. Cell Biol. 122:1993;191-198.
52. Lefebvre O., Chenard M.P., Masson R., Linares J., Dierich A., Le Meur M., Wendling C., Tomasetto C., Chambon P., Rio M.C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 274:1996;259-262.
53. Liu D., El-Hariry I., Karayiannakis A.J., Wilding J., chinery R., Kmiot W., McCrea P., Gullick W.J., Pignatelli M. Phosphorylation of β-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab. Invest. 77:1997;557-563.
54. Luqmani Y., Bennett C., Paterson I., Corbishley C., Rio M.C., Chambon P., Ryall G. Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int. J. Cancer. 44:1989;806-812.
55. Luqmani Y.A., Ryall G., Shousha S., Coombes R.C. An immunohistochemical survey of pS2 expression in human epithelial cancers. Int. J. Cancer. 50:1992;302-304.
56. Machado J.C., Carneiro F., Ribeiro P., Blin N., Sobrinho-Simoes M. pS2 protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study. Eur. J. Cancer. 32A:1996;1585-1590.
57. Martin V., Ribieras S., Song-Wang X., Rio M.C., Dante R. Genomic sequencing indicates a correlation between DNA hypomethylation in the 5′ region of the pS2 gene and its expression in human breast cancer cell lines. Gene. 157:1995;261-264.
58. Martin V., Ribieras S., Song-Wang X.G., Lasne Y., Frappart L., Rio M.C., Dante R. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers. J. Cell. Biochem. 65:1997;95-106.
59. Mashimo H., Podolsky D.K., Fishman M.C. Structure and expression of murine intestinal trefoil factor: high evolutionary conservation and postnatal expression. Biochem. Biophys. Res. Commun. 210:1995;31-37.
60. Mashimo H., Wu D.C., Podolsky D.K., Fishman M.C. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:1996;262-265.
61. Masiakowski P., Breathnach R., Block J., Gannon F., Krust A., Chambon P. Cloning of cDNA sequences of hormone-regulated genes from the MCF7 human breast cancer cell line. Nucleic Acids Res. 10:1982;7895-7903.
62. May F.E.B., Westley B.R. Identification and characterization of estrogen-regulated mRNA in human breast cancer cells. J. Biol. Chem. 263:1988;12901-12908.
63. May F.E.B., Westley B.R. Close physical linkage of the genes encoding the pNR-2/pS2 protein and human spasmolytic protein (hSP). Hum. Genet. 99:1997;303-307.
64. May F.E.B., Westley B.R. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells. J. Pathol. 182:1997;404-413.
65. May F.E.B., Westley B.R. Trefoil proteins: their role in normal and malignant cells. J. Pathol. 183:1997;4-7.
66. Miyashita S., Hirota M., Yamamoto T., Shiroyama C., Furukawa Y., Hayashi K. Effect of basic fibroblast growth factor on synthesis/secretion of pS2 protein by human breast cancer cells (MCF-7). Eur. J. Biochem. 225:1994;1041-1046.
67. Miyashita S., Nomoto H., Konishi H., Hayashi K. Estimation of pS2 protein level in human body fluids by a sensitive two-site enzyme immunoassay. Clin. Chim. Acta. A228:1994;71-81.
68. Nunez A.M., Berry M., Imler J.L., Chambon P. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumor promoter (TPA), the c-Ha-ras oncoprotein and c-jun protein. EMBO J. 8:1989;823-829.
69. Ogata H., Podolsky D. Trefoil peptide expression and secretion is regulated by neuropeptides and acetylcholine. Am. J. Physiol. 273:1997;G348-G354.
70. Ogata H., Inoue N., Podolsky D. Identification of a goblet cell-specific enhancer element in the rat intestinal trefoil factor gene promoter bound by a goblet cell nuclear protein. J. Biol. Chem. 273:1998;3060-3067.
71. Otto W.R., Rao J., Cox H.M., KotzianC E., Lee Y., Goodlad R.A., Lane A., Gorman M., Freemont P.A., Hansen H.F., Pappin D., Wright N.A. Effects of pancreatic spasmolytic polypeptide (PSP) on epithelial cell function. Eur. J. Biochem. 235:1996;64-72.
72. Piggot N., Henry J., May F.E.B., Westley B.R. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J. Pathol. 163:1991;95-104.
73. Playford R.J., Marchbank T., Chinery R., Evison R., Pignatelli M., Boulton R.A., Thim L., Hanby A.H. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology. 108:1995;108-116.
74. Playford R.J., Marchbank T., Goodlad R.A., Chinery R., Poulsom R., Hanby A.M. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl. Acad. Sci. USA. 93:1996;2137-2142.
75. Podolski D.K., Lynch-Devaney K., Stow J.L., Oates P., Murgue B., DeBeaumont M., Sands B.E., Mahida Y.R. Identification of human intestinal trefoil factor. J. Biol. Chem. 268:1993;6694-6702.
76. Polshakov V.I., Williams M.A., GargaroT R., Frenkiel A., Westley B.R., Chadwick M.P., May F.E., Feeney J. High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein. J. Mol. Biol. 267:1997;418-432.
77. Poulsom R. Trefoil peptides. Bail. Clin. Gastrol. 10:1996;113-134.
78. Poulsom R., Hanby A.M., Lalani E.N., Hauser F., Hoffmann W., Stamp G.W. Intestinal trefoil factor (TFF3) and pS2 (TFF1), but not spasmolytic polypeptide (TFF2) mRNAs are coexpressed in normal, hyperplastic, and neoplastic human breast epithelium. J. Pathol. 183:1997;30-38.
79. Predine P., Spyratos F., Prud'homme J.F., Andrieu C., Hacene K., Brunet M., Pallud C., Milgrom E. Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Cancer. 69:1992;2116-2123.
80. Probst J.C., Skutella T., Muller-Schmid A., Jirikowski G.F., Hoffmann W. Molecular and cellular analysis of rP1.B in the rat hypothalamus: in situ hybridization and immunohistochemistry of a new P-domain neuropeptide. Brain Res. Mol. Brain Res. 3:1995;269-276.
81. Probst J.C., Zetzsche T., Weber M., Theilemann P., Skutella T., Landgraf R., Jirikowski G.F. Human intestinal trefoil factor is expressed in human hypothalamus and pituitary. Evidence for a novel neuropeptide. FASEB J. 10:1996;1518-1523.
82. Prud'homme J.F., Fridlansky F., Le Cunff M., Atger M., Mercier-Bodart C., Pichon M.F., Milgrom E. Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA. 4:1985;11-21.
83. Prud'homme J.F., Jolivet A., Pichon M.F., Savouret J.F., Milgrom E. Monoclonal antibodies against native ant denatured forms of estrogen-induced breast cancer protein (BCEI/pS2) obtained by expression in Escherichia coli. Cancer Res. 50:1990;2390-2396.
84. Rasmussen T.N., Raaberg L., Poulsen S.S., Thim L., Holst J.J. Immunohistochemical localization of pancreatic spasmolytic polypeptide (PSP) in the pig. Histochemistry. 98:1992;113-119.
85. Rio M.C., Bellocq J.P., Gairard B., Rasmussen U., Krust A., Koehl C., Calderoli H., Schiff V., Renaud R., Chambon P. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the oestrogen and progesterone receptors and the oncogene ErbB2. Proc. Natl. Acad. Sci. USA. 84:1987;9243-9247.
86. Rio M.C., Lepage P., Diemunsch P., Roitsch C., Chambon P. Structure primaire de la protéine humaine pS2. C.R. Acad. Sci. Paris. 307iii:1988;825-831.
87. Rio M.C., Bellocq J.P., Daniel J.Y., Tomasetto C., Lathe R., Chenard M.P., Batzenschlager A., Chambon P. Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science. 241:1988;705-708.
88. Rio M.C., Chambon P. The pS2 gene, mRNA and protein: a potential marker for human breast cancer. Cancer Cells. 2:1990;269-274.
89. Rio M.C., Chenard M.P., Wolf C., Marcellin L., Tomasetto C., Lathe R., Bellocq J.P., Chambon P. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology. 100:1991;375-379.
90. Sands B.E., Ogata H., Lynch-Devaney K., de Beaumont M., Ezzell R.M., Podolsky D.K. Molecular cloning of the rat intestinal trefoil factor gene. Characterization of an intestinal goblet cell-associated promoter. J. Biol. Chem. 270:1995;9353-9361.
91. Sands B.E., Podolsky D.K. The trefoil peptide family. Annu. Rev. Physiol. 58:1996;253-273.
92. Schmitt H., Wundrack I., Beck S., Gott P., Welter C., Shizuya H., Simon M.I., Blin N. A third P-domain peptide gene (TFF3), human intestinal trefoil factor, maps to 21q22.3. Cytogenet. Cell Genet. 72:1996;299-302.
93. Schwartz L.H., Koerner F.C., Edgerton S.M., Sawicka J.M., Rio M.C., Bellocq J.P., Chambon P., Thor A. pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res. 51:1991;624-628.
94. Seib T., Blin N., Hilgert K., Seifert M., Theisinger B., Engel M., Dooley S., Zang K.D., Welter C. The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3. Genomics. 40:1997;200-202.
95. Seitz G., Theisinger B., Tomasetto C., Rio M.C., Chambon P., Blin N., Welter C. Breast cancer-associated protein pS2 expression in tumors of the biliary tract. Am. J. Gastroenterol. 86:1991;1491-1494.
96. Shousha S., Luqmani Y.A., Sannino P., Rio M.C., Coombes R.C., Theodorou N.A. pS2 immunostaining of colorectal cancer. Mod. Pathol. 6:1993;446-448.
97. Skilton R.A., Luqmani Y., McClelland R.A., Coombes R.C. Characterisation of a messenger RNA selectively expressed in human breast cancer. Br. J. Cancer. 60:1989;168-175.
98. Suemori S., Lynch-Devaney K., Podolsky D.K. Identification and characterisation of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc. Natl. Acad. Sci. USA. 88:1991;1017-11021.
99. Takahashi H., Kida N., Fujii R., Tanaka K.I., Ohta M., Mori K., Hayashi K. Expression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinoma. FEBS Lett. 261:1990;283-286.
100. Tanaka S., Podolski D.K., Engel E., Guth P.H., Kaunitz J.D. Human spasmolytic polypeptide decreases proton permeation through gastric mucus in-vivo and in-vitro. Am. J. Physiol.-Gastrointest. Liver Physiol. 35:1997;G1473-G1480.
101. Theisinger B., Welter C., Seitz G., Rio M.C., Lathe R., Chambon P., Blin N. Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur. J. Cancer. 27:1991;770-773.
102. Theisinger B., Seitz G., Dooley S., Welter C. A 2nd trefoil protein, itf/hp1.b, is transcribed in human breast-cancer. Breast Cancer Res. Treatm. 38:1996;145-151.
103. Thim L., Thomsen J., Christensen M., Jorgensen K.H. The amino acid sequence of pancreatic spasmolytic polypeptide. Biochim. Biophys. Acta. 827:1985;410-418.
104. Thim L. A surprising sequence homology. Biochem. J. 253:1988;309.
105. Thim L. A new family of growth factor-like peptides. FEBS Lett. 250:1989;85-90.
106. Thim L., Norris K., Norris F., Nielsen P.F., Bjorn S.E., Christensen M., Petersen J. Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett. 318:1993;345-352.
107. Thim L., Woldike H.F., Nielsen P.F., Christensen M., Lynch-Devaney K., Podolsky D.K. Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry. 34:1995;4757-4764.
108. Thim L. Trefoil peptides: from structure to function. Cell Mol. Life Sci. 53:1997;888-903.
109. Tomasetto C., Wolf C., Rio M.C., Le Meur M., Gerlinger P., Chambon P., Lathe R. Breast cancer protein PS2 synthesis in mammary gland of transgenic mice and secretion into milk. Mol. Endocrinol. 3:1989;1579-1584.
110. Tomasetto C., Rio M.C., Gautier C., Wolf C., Hareuvani M., Chambon P., Lathe R. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J. 9:1990;407-414.
111. Tomasetto C., Rockel N., Mattei M.G., Fujita R., Rio M.C. The gene encoding the human spasmolytic protein (SML1/hSP) is in 21q22.3, physically linked to the homologous breast cancer marker gene BCEI/pS2. Genomics. 13:1992;1328-1330.
112. Tomita M., Itoh H., Ishikawa N., Higa A., Ide H., Murakumo Y., Maruyama H., Koga Y., Nawa Y. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. Biochem. J. 311:1995;293-297.
113. Wang D.G., Johnston C.F., Liu W.H., Sloan J.M., Buchanan K.D. Expression of a breast-cancer-associated protein (pS2) in human neuro-endocrine tumors. Int. J. Cancer. 74:1997;270-274.
114. Welter C., Theisinger B., Seitz G., Tomasetto C., Rio M.C., Chambon P., Blin N. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab. Invest. 66:1992;187-192.
115. Welter C., Theisinger B., Rio M.C., Seitz G., Schüder G., Blin N. Expression pattern of breast cancer associated protein pS2/BCEI in colorectal tumors. Int. J. Cancer. 56:1994;52-55.
116. Williams R., Stamp G.W., Gilbert C., Pignatelli M., Lalani E.N. pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3D collagen gel. J. Cell Sci. 109:1996;73.
117. Wright N.A., Pike C., Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 343:1990;82-85.
118. Wright N.A., Poulson R., Stamp G.W., Hall P.A., Jeffery R., Longcroft J., Rio M.C., Tomasetto C., Chambon P. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J. Pathol. 162:1990;279-284.
119. Wright N.A., Poulsom R., Stamp G., Van Noorden S., Sarraf C., Elia G., Ahnen D., Jeffery R., Longcroft J., Pike C., Rio M.C., Chambon P. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology. 104:1993;12-20.
120. Wright N.A., Hoffmann W., Otto W.R., Rio M.C., Thim L. Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett. 408:1997;121-123.
121. Yang Y., Chisholm G.D., Habib F.K. The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostate. Prostate. 21:1992;201-208.
122. Zaretsky J.Z., Weiss M., Tsarfaty I., Hareuveni M., Wreschner D.H., Keydar I. Expression of genes coding for pS2, c-erbB2, estrogen receptor and the H23 breast tumor-associated antigen. A comparative analysis in breast cancer. FEBS Lett. 265:1990;46-50.